Digital PCR offers advantages in cancer research, enabling the accurate quantification of targets of interest in liquid biopsy (cfDNA) samples. It can routinely detect rare mutations in a high background of wild-type cfDNA. This event discusses "The power of two: automated sample preparation on the EZ2 Connect and analysis using the QIAcuity Digital PCR System." This automated workflow starts with high-volume sample processing and ends in ultra-low mutation detection, generating reliable results from the most complex samples.

You can look forward to a focused discussion on the challenges you face every day in the lab when working with such samples.

You can submit the questions you have for our experts here or ask them during the live event.